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Translation initiationPoor oxygenation (hypoxia) inﬂuences important physiological and pathological situations, including devel-
opment, ischemia, stroke and cancer. Hypoxia induces protein synthesis inhibition that is primarily regulated
at the level of initiation step. This regulation generally takes place at two stages, the phosphorylation of the
subunit α of the eukaryotic initiation factor (eIF) 2 and the inhibition of the eIF4F complex availability by de-
phosphorylation of the inhibitory protein 4E-BP1 (eukaryotic initiation factor 4E-binding protein 1). The con-
tribution of each of them is mainly dependent of the extent of the oxygen deprivation. We have evaluated the
regulation of hypoxia-induced translation inhibition in nerve growth factor (NGF)-differentiated PC12 cells sub-
jected to a low oxygen concentration (0.1%) at several times. Our ﬁndings indicate that protein synthesis inhibi-
tion occurs primarily by the disruption of eIF4F complex through 4E-BP1 dephosphorylation, which is produced
by the inhibition of the mammalian target of rapamycin (mTOR) activity via the activation of REDD1 (regulated
in development and DNA damage 1) protein in a hypoxia-inducible factor 1 (HIF1)-dependent manner, as well
as the translocation of eIF4E to the nucleus. In addition, this mechanism is reinforced by the increase in 4E-BP1
levels, mainly at prolonged times of hypoxia.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Hypoxia participates in important physiological and pathological
situations such as development, ischemia, and cancer. Among other
effects, hypoxia affects protein synthesis mainly regulating the initia-
tion stage which can be controlled at two steps. The ﬁrst corresponds
to ternary complex formation between eukaryotic initiation factor
(eIF) 2, GTP and Met-tRNAi, which is prior to 43S initiation complex
formation. Protein eIF2B is also required at this stage for guanine-
nucleotide exchange on eIF2, in order to regenerate active eIF2-GTP.
The phosphorylation of the eIF2α subunit at serine 51 acts as a com-
petitive inhibitor of eIF2B activity. Because eIF2B exists in smaller
amounts than eIF2α (about 20–30%), small increase in eIF2α phos-
phorylation can dramatically suppress translation initiation [1,2].-binding protein 1; Akt, serine/
d protein kinase; eIF, eukaryotic
ducible factor; mTOR, mamma-
, regulated in development and
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edicina, Universidad Complu-
l rights reserved.The second predominant process subjected to ﬁne control is the re-
cruitment of the 40S ribosomal subunit to the mRNA. This occurs
through 5′cap structure recognition (m7GpppX, where “X” is any nu-
cleotide) by the eukaryotic initiation factor 4F (eIF4F). In higher eu-
karyotes, eIF4F consists of three subunits: eIF4E, the cap-binding
subunit, eIF4A, an ATP-dependent RNA helicase, and eIF4G that serves
as a scaffold protein for assembly of eIF4E and eIF4A into the eIF4F
complex. Under normal conditions eIF4E is considered to be rate-
limiting for the formation of eIF4F. The availability of eIF4E is con-
trolled by the 4E-binding protein family (4E-BPs), a family of transla-
tional repressor proteins. Actually, 4E-BP1, 4E-BP2 and 4E-BP3 are the
three known members of the mammalian 4E-BPs, which are encoded
by three different genes and had been characterized for their capacity
to bind speciﬁcally to eIF4E inhibiting its function. Because they share
with eIF4G a common binding motif to eIF4E that is mutually exclu-
sive, hypophosphorylated 4E-BPs bind with high afﬁnity to eIF4E
and compete with eIF4G, preventing 4F complex formation [3].
Upon phosphorylation, 4E-BP association with eIF4E is abrogated
and translation inhibition restored. 4E-BP1, the best characterized
4E-BP protein, is one of the main effectors of mammalian target of
rapamycin (mTOR), serine/threonine-protein kinase in the phosphoi-
nositide 3-kinase (PI3-kinase)/Akt (RAC serine/threonine-protein ki-
nase, also named protein kinase B, PKB) signaling pathway that
integrates signals from extracellular stimuli, amino acid availability,
and oxygen and energy status of the cells [4].
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multifactorial and involve both control points mentioned above
being the contribution of each of them mainly dependent of the ex-
tent of the oxygen deprivation. Thus, it has been established that se-
vere hypoxia (b0.05%) causes fast phosphorylation of eIF2α (30 min
of exposure) [5,6] and shows a partial recovery after 4–8 h. In con-
trast, phosphorylation of eIF2α during moderate hypoxia (0.2% and
1% oxygen) requires signiﬁcantly longer hypoxic exposures (>8 h).
Phosphorylation of eIF2α during hypoxia needs activation of the ER
resident kinase PERK, which is known to be involved in the unfolded
protein response (UPR) [7]. In addition, several reports support that
both moderate and severe hypoxia cause dephosphorylation of 4E-
BP1, the corresponding increase in the association of this protein
with eIF4E and, consequently, the reduction in the association be-
tween eIF4E and eIF4G [5,8,9].
Here, we have analyzed the regulation of the translation in an in
vitro model of hypoxia obtained by subjecting NGF-differentiated
PC12 cells to a low oxygen concentration (0.1%). Our results clearly
indicate that the main mechanism implicated in the translation inhi-
bition induced by hypoxia in our model is the disruption of eIF4F
complex that is affected by both translocation of eIF4E from the cyto-
plasm to the nucleus as by 4E-BP1 expression level of and its dephos-
phorylation, via HIF/REDD1 pathway.
2. Materials and methods
2.1. Cell Cultures and experimental model
PC12 cells were maintained as monolayer cultures in 75-cm2 tis-
sue culture ﬂasks in complete medium, CM [Dulbecco's modiﬁed
Eagle's medium (DMEM)] supplemented with 10% horse serum and
5% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin
and 25 μg/ml amphotericin, in a humidiﬁed 5% CO2/95% air incubator
at 37 °C. Cells were subcultured either in collagen-coated 24-well
plates at a density of 4×104 cells/well for cell viability, protein syn-
thesis rate and ATP determination, in 6-well plates (1.6×105 cells/
well) or in 100 mm diameter dish (8×105 cells/dish) for all other ex-
periments. Differentiation of cells was performed in low serum medi-
um, LSM (DMEM supplemented with 1% horse serum, 100 U/ml
penicillin, 100 μg/ml streptomycin and 25 μg/ml amphotericin), in
the presence of 100 ng/ml NGF-7S (Alomone Labs, Israel) as de-
scribed [10]. Medium was changed twice (days 2 and 4) during the
experiment (5-day period).
Hypoxia (0.1% O2) was achieved using an In Vivo 200 hypoxic sta-
tion (Ruskinn Technologies, Bridgend, UK). Brieﬂy, differentiated cells
were washed with LSM medium and maintained under hypoxic con-
dition during 4 or 24 h. Control cells were maintained for the same
times in LSM without NGF in a humidiﬁed 5% CO2/95% air incubator
at 37 °C.
2.2. Protein synthesis rate measurement
To calculate the protein synthesis rate, cells were plated on
24 mm-diameter multiwell dishes, and then 8 μCi/well of [3H]methi-
onine was added 1 h before the end of the period of hypoxia. Incorpo-
ration of methionine into protein was determined by precipitation
with trichloroacetic acid as previously described [10]. The results
are calculated as cpm of [3H]methionine incorporated/mg of protein
and expressed as the percentage relative to control.
2.3. ATP determination
The amount of cellular ATP was measured with a luminescence-
based assay kit (Sigma, Madrid, Spain). Fresh cells were washed
with 0.25 ml of cold buffer consisting of 0.1 M Na2HPO4 pH 7.5 and
5 mM EDTA, centrifuged at 1500 ×g for 5 min, resuspended in0.2 ml of the same buffer and lysed by sonication (4×10 s). After cen-
trifugation at 10,000 ×g over 15 min, the supernatant (6–8 μg pro-
tein) was immediately used for ATP determination. Total ATP was
calculated from a standard curve prepared with known amounts of
ATP as nmol per mg of protein, and expressed as percentage relative
to the control.
2.4. Antibodies
Goat eIF4AI and rabbit AMPKα1/2 (Thr172), HIFα antibodies
were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mono-
clonal AMPKα and rabbit eEF2, eEF2 (Thr56), Akt, Akt (Ser473P) and
4E-BP1 antibodies were from Cell Signalling Technology (Danvers,
MA, USA). Rabbit REDD1 antibody was obtained from Proteintech
Europe Ltd (Manchester, UK). Monoclonal anti-eIF2α, anti-eIF4E,
and anti-β-actin were obtained from AbCam (Cambridge, UK), BD
Biosciences (Franklin Lakes, NJ, USA), and Sigma, respectively.
Monoclonal HIFα antibody was from R&D (Minneapolis, MN,
USA). The anti-eIF4G antibody was generously provided by Dr. S.J.
Morley. Mouse and rabbit-IgG conjugated peroxidase were from
GE Healthcare (Barcelona, Spain) and goat-IgG conjugated peroxi-
dase was from Santa Cruz Biotechnology. Mouse-IgG conjugated al-
kaline phosphatase was from Sigma.
2.5. Protein extraction
At the end of the treatments, the medium was removed and the
cells were washed twice with ice-cold buffer LC (20 mM Tris–HCl
pH 7.6, 1 mM DTT, 1 mM EDTA, 1 mM PMSF, 1 mM benzamidine,
2 mM sodium molybdate, 2 mM sodium β-glycerophosphate,
0.2 mM sodium orthovanadate, 120 mM KCl, 1 μg/ml leupeptin and
pepstatin A, and 10 μg/ml antipain) and then lysed in the same buffer
containing 1% Triton X-100 (50 μl/106 cells). Cell lysates were centri-
fuged at 12,000 ×g for 10 min and the supernatants (PMS) were kept
at−80 °C until used. Alternatively, extracts corresponding whole ly-
sates were obtained using the buffer A from the Panorama Cell Signal-
ing Antibody Microarray kit (Sigma) in accordance with the
manufacturer's instructions. Protein determination was performed
by the method of Bradford (Bio-Rad, Barcelona, Spain) [11].
For the determination of HIF-1α levels, cells were lysed in HIF
buffer (250 mM Tris–HCl pH 6.8, 10% glycerol, 20 mM DTT, 6% SDS
and 1% bromofenol blue), passed it through a syringe needle ten
times and sonicated 5 min twice and ﬁnally centrifuged at
12,000 ×g for 10 min.
2.6. Western blot analysis
Cell lysates (35 μg) were resolved by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE), at the conditions indicat-
ed in ﬁgure legends, and transferred onto PVDF membranes.
Monoclonal antibodies were incubated for 1–2 h at room tempera-
ture and polyclonal antibodies were incubated at 4 °C overnight.
After washed, membranes were incubated with the corresponding
peroxidase-conjugated secondary antibody for 1 h at room tempera-
ture, developed with enhanced chemiluminescence's kits (GE Health-
care) and exposed to hyperﬁlm. Full Range Rainbow molecular
weight markers (GE Healthcare) were used in all the experiments.
β-Actin was used as control to monitor homogeneity of loading. To
determine the eIF2α and eIF4E phosphorylation state, lysates were
adjusted to 35 μg of protein per sample, resolved in horizontal iso-
electric focusing slab gels (IEF) and analyzed by protein immunoblot
as described previously [12]. Proteins were stained and then incubat-
ed in the presence of monoclonal anti-eIF4E and anti-eIF2α. Stained
bands were scanned and quantiﬁed with an analyzer equipped with
the ImagequantTL software package (GE Healthcare).
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status 2-D gel electrophoresis were performed as describe previously
[13]. Brieﬂy, samples containing 50 μg of cell lysates, 8.5 M urea and
5% β-mercaptoethanol were loaded into horizontal IEF slab gels as
the ﬁrst dimension (pH 3–10 nonlinear gradient). In the second di-
mension, SDS-PAGE was performed in 12% acrylamide (2.6% cross-
linking) gels (1.0 mm thick), with an IEF strip used as a stacking gel.
2.7. Measurement of 4E-BP1/eIF4E and eIF4G/eIF4E complexes
The amount of 4E-BP1 and eIF4G recovered when eIF4E was puri-
ﬁed using m7GTP-sepharose was carried out as described previously
[12]. Protein lysate (100–200 μg) was incubated with 30 μl of
m7GTP-sepharose for 30 min at 4 °C, and washed with buffer LC
plus 0.1 mM GTP. Proteins were eluted with SDS sample buffer and
then subjected to electrophoresis; for eIF4G quantiﬁcation 7.5% poly-
acrylamide gel was used, and for both eIF4E and 4E-BP1 quantiﬁca-
tion 15% polyacrylamide gel was used. eIF4G, eIF4E and 4E-BP1
levels in the complex were detected by immunoblot analysis and
quantiﬁed as described above for the individual factors.
2.8. mRNA quantitation by quantitative PCR analysis
Total RNA obtained from hypoxic and normoxic cells using TRI-
ZOL® Reagent (Invitrogen, Barcelona, Spain) were transcribed to
cDNA using the iScript™ cDNA Synthesis Kit, (Bio-Rad) and used as
template for the quantitative PCR assay (Kit SYBR® Premix Ex
Taq™, TAKARA BIO INC). PCR was performed in an iCycler IQ system
(Bio-Rad) and the results were analyzed with iQ5 2.0 Standard Edi-
tion Optical System Software (Bio-Rad). Data were normalized with
P0 levels and expressed as the ratio between hypoxia and control.
The primers used in these reactions are listed in Table 1.
2.9. Immunolocalization
PC12 cells were cultured on glass coverslips under the conditions
described above. After 4 or 24 h of hypoxia, cells were ﬁxed and per-
meabilized with methanol for 20 min at −20 °C, and incubated with
anti-HIF1α antibody diluted 1/50 overnight. When coimmunochem-
istry was done, the cells were incubated with anti-4E-BP1 (53H11)
diluted 1/50 overnight following by incubation with anti-eIF4E dilut-
ed 1/100 1 h. After wash, the coverlisps were incubated with the cor-
responding secondary antibodies diluted 1/200 (anti-rabbit
alexaﬂuor 488 or anti-mouse alexaﬂuor 568) (GE Healthcare) for
1 h, and the cells were mounted on slides in glycerol-buffer contain-
ing p-phenyl-enediamine and 30 AM bis-benzimide (Hoechst
33342) for nuclear staining. Controls were made by omitting the pri-
mary antibody. Subcellular localization of proteins was assessed by
confocal microcopy (Nikon ECLIPSE Ti-e inverted ﬂuorescence micro-
scope equipped with a Nikon C1 laser scanning confocal microscope
system (Nikon Corp., USA)) using a 60× oil immersion objective.Table 1
Primer used for the quantitative PCR.
Target Name Sequence
P0 5′ P0 5′-CCTCATATCCGGGGGAATGTG-3′
3′ P0 5′-GCAGCAGCTGGCACCTTATTG-3′
eIF4E 5′ eIF4E 5′-ATGGCGACTGTGGAACCGGA-3′
3′ eIF4E 5′-TTAAACAACAAACCTATTTT-3′
4E-BP1 5′ 4E-BP1 5′-ATGTCCGGGGGCAGCAGCTG-3′
3′ 4E-BP1 5′-TTAAATGTCCATCTCAAACT-3′
HIF-1α 5′ HIF 5′-AGTGTACCCTAACTAGCCG-3′
3′ HIF 5′-TTCACAAATCAGCACCAAGC-3′
REDD1 5′ REDD1 5′-TCTGGACCCCAGTCTAGTGC-3′
3′ REDD1 5′-ACCAGGGACCAAGGAAGAGT-3′2.10. siRNA transfection
To suppress REDD1expression, PC12 cells differentiated with NGF
for two days were transfected with nonspeciﬁc [14] or DDIT4 siRNAs
(Qiagen, Frederick, MD, USA) using Lipofectamine 2000 reagent (Invi-
trogen, Carlsbad, CA) following the supplier's instructions (100 pmol
of siRNA in 6-well plates). Fresh medium containing 2xNGF was
added after 6 h of transfection and hypoxia (0.1% O2) was achieved
72 h post-transfection as described above.
2.11. Statistical analysis
Results are expressed as means±standard error of the mean
(SEM) for n independent experiments, as indicated in the legend to
each ﬁgure and analyzed using GraphPad Prism v4 (San Diego, CA,
USA). Statistical comparisons between samples were made by Stu-
dent's t-test. Signiﬁcance was assumed at Pb0.05.
3. Results
3.1. Analysis of the initiation factors
It has been previously reported that hypoxia regulates translation
through two distinct pathways: the phosphorylation of eIF2α and the
disruption of the eIF4F complex, the last mediated by the dephos-
phorylation of 4E-BP1. In our model of NGF-differentiated PC12
cells, we observed that 4 h or 24 h of hypoxia (0.1% O2) produced a
signiﬁcant protein synthesis inhibition (30%) that, moreover, was ac-
companied by a decrease in the ATP levels only after 24 h of hypoxia
(Fig. 1A, B). In addition, we also analyzed the effect of hypoxia on
eIF2α phosphorylation by SDS-PAGE (top) or IEF (bottom) and im-
munoblot showing that the eIF2αP levels did not change after 4 h
whereas a signiﬁcant, although a slight increase of eIF2αP can be ob-
served after 24 h of hypoxia (Fig. 1C, Supplemental Fig. S1A).
Next, we also examined whether or not eIF4F activity played some
role on the effect produced by hypoxia. At this respect, we ﬁrst stud-
ied the levels of all the components of eIF4F complex (eIF4G, eIF4A
and eIF4E) demonstrating that, eIF4G and eIF4A levels did not change
signiﬁcantly (Fig. 1D), whereas a reduction of eIF4E levels can be ob-
served at 4 h and 24 h of hypoxia being signiﬁcant at the last time
(Supplemental Fig. S1B). Therefore, the eIF4E phosphorylation status
was also analyzed and a signiﬁcant decrease after 24 h of hypoxia
(24% of eIF4EP) relative to control cells (39%; Fig. 1D, bottom, Supple-
mental Fig. S1C) was found.
In addition, we analyzed the phosphorylation status and levels of
4E-BP1 in hypoxia by SDS-PAGE and Western blotting taking into ac-
count that the inhibitory regulator 4E-BP1 can be resolved in one-
dimensional SDS-PAGE in three bands, named α, β and γ forms in
order of decreasing electrophoretic mobility. As shown in Fig. 1E,
the total levels of 4E-BP1 (sum of three isoforms resolved by SDS-
PAGE) increased signiﬁcantly after hypoxia (151% and 131% after 4
and 24 h of hypoxia, respectively, Fig. S1B). Moreover, a signiﬁcant
increase in the hypophosphorylated (α) isoform of 4E-BP1 can be
observed after 4 and 24 h of hypoxia. To further conﬁrm the changes
in the isoforms of 4E-BP1, we have also analyzed the phosphoryla-
tion status of 4E-BP1 by two-dimensional gel electrophoresis
(Fig. 1E, bottom). Four different spots were detected in both control
and hypoxic samples, the most basic corresponding to the hypopho-
sphorylated α form of 4E-BP1; two additional spots, named as β′
and β″ corresponding to the phosphorylated β form; and one spot
in the most acid position corresponding to the hyperphosphorylated
form. The data of the quantiﬁcation of the different 4E-BP1 isoforms
indicated that the increase in the levels of 4EBP1α form is accompa-
nied by a decrease in the most phosphorylated γ form of the protein
(Supplemental Fig. S2).
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Fig. 1. Protein synthesis rate, ATP levels and initiation factor modiﬁcations in NGF differentiated PC12 cells under hypoxia. NGF differentiated PC12 cells were subjected to
0.1% O2 during 4 h and 24 h. Protein synthesis rate (A) was analyzed by measuring the incorporation of 3H-methionine into protein, and ATP levels (B) were determined
using a luminescence-based assay kit as described in the Materials and methods section. Results are expressed as the percentage of control (21% O2) values and represent
the mean±SEM of 3–5 different experiments. Statistical signiﬁcance: *pb0.05, **pb0.01. C) Analysis of the phosphorylation status and expression level of eIF2α. Cell lysates
(15–35 μg) from control or hypoxic cells obtained as described in the Materials and methods section were subjected to SDS-PAGE (top) or IEF (bottom) and analyzed by
Western blot using anti-eIF2α and anti-eIF2α-P antibodies. nP-eIF2α, non-phosphorylated eIF2α; eIF2α-P, phosphorylated eIF2α. D) Analysis of the expression level of
the proteins of the eIF4F complex by Western blot using anti-eIF4G, anti-eIF4A and anti-eIF4E antibodies. eIF4E phosphorylation status was analyzed by IEF and Western
blot as in C. nP-eIF4E, non-phosphorylated eIF4E; eIF4E-P, phosphorylated eIF4E. E) Analysis of total levels and phosphorylation status of 4E-BP1 by SDS-PAGE (top) and
two-dimensional gel electrophoresis (bottom) using anti-4E-BP1 antibody. F) Analysis of 4E-BP1 and eIF4G association with eIF4E. Cell lysates (200 μg) were subjected to
m7GTP-sepharose chromatography following Western blot using antibodies against eIF4E, 4E-BP1 and eIF4G. Representative blots are shown and the quantiﬁcation of the
western blots is shown in the Supplemental material. β-Actin was used as loading control.
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The binding of eIF4E to dephosphorylated 4E-BPs has been
shown to prevent eIF4F formation by sequestering eIF4E and impair-
ing cap-dependent but not cap-independent translation [4,15]. To
establish whether or not eIF4F formation is inhibited during hypoxia,
we have determined the level of 4E-BP1 and eIF4G that co-purifywith eIF4E as a measure of the eIF4F complex formation. As
expected, the association of 4E-BP1 with eIF4E increased signiﬁcant-
ly during hypoxia and, because 4E-BP1 competes with eIF4G to bind
eIF4E, this increased binding of 4E-BP1 to eIF4E induced the inhibi-
tion in the eIF4F complex formation as indicated by the signiﬁcant
decrease in the association of eIF4G with eIF4E observed after hyp-
oxia (Fig. 1F and Supplemental Fig. S3).
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Two surprising results have been found in our model: the decrease
of eIF4E and the signiﬁcant increase in 4E-BP1 levels induced by hyp-
oxia. Because the lysates obtained using buffer LC could not contain
the total protein of the cells, we have determined the levels of both
factors using another buffer able to extract whole protein from the
cells. The analysis of eIF4E and 4E-BP1 in these lysates showed no
changes in total levels of eIF4E after 4 h and 24 h meanwhile 4E-BP1
levels increased under hypoxia being statistically signiﬁcant after
24 h (Fig. 2). Moreover, the analysis of the levels of the 4E-BP1 and
eIF4E mRNAs by quantitative PCR showed an increase of 4E-BP1
mRNA at 24 h of hypoxia (Fig. 2, bottom).3.4. Subcellular localization of 4E-BP1 with eIF4E changes during hypoxia
Our above results showing discrepancies between eIF4E and 4E-
BP1 expression in cytoplasmic fractions (considering that 1% of tri-
ton X100 detergent is unable to disrupt nucleus from PC12 cells) or
in total lysates suggested the possibility that eIF4E could beeIF4E
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Fig. 2. eIF4E and 4E-BP1 protein and mRNA levels. NGF differentiated PC12 cells were
subjected to 0.1% O2 during 4 h and 24 h. Whole lysates (10 μg) obtained using the
buffer A from the Panorama Cell Signaling Antibody Microarray kit (Sigma) were
immunoblotted with anti-eIF4E and anti-4E-BP1 antibodies. A representative blot is
shown in the top of the ﬁgure. Results are expressed as the percentage of control values
and represent the mean±SEM of 3 different experiments. mRNA levels were measured
using qRT-PCR as described in the Materials and methods section. Data are normalized
relative to P0 mRNA levels and the value for the control was considered as 1. Each ex-
periment was done in triplicate twice and data corresponding to the mean±SEM from
four different experiments. Statistical signiﬁcance: *pb0.05.translocated to the nucleus or to stress granules, as has been de-
scribed in other hypoxia models [5,16]. Experiments of immunocy-
tochemistry using eIF4E and TIA colocalization indicated that stress
granules are not induced in our model, excluding this mechanism
(data not shown). Next, we studied the cellular distribution of
eF4E and 4E-BP1 using subcellular fractionation and immunoﬂuo-
rescence analysis. As shown in Fig. 3A, the detection of eIF4E in
the nuclear fraction was hardly observed. The quantiﬁcation of
three different experiments indicated that around 3% of eIF4E was
present in this fraction without substantial changes between hyp-
oxic and control cells. Moreover, 4E-BP1 was not detected in the
nuclear fraction. Previous studies using biochemical fractionation
concluded that 4E-BP1 was only cytoplasmic [17,18]; however, dur-
ing the fractionation procedure 4E-BP1 can be leaked into the cyto-
plasmic compartment due to its small molecular mass. In 2008,
Rong et al. [19] using immunoﬂuorescence demonstrated that a
considerable fraction of 4E-BP1 was present into the nucleus in
multiple cell lines and tissues. Taking into account these results,
we have performed immunocytochemistry experiments, with the
same antibody used by these authors, and 4E-BP1 and eIF4E locali-
zation was analyzed using a confocal microscope. As shown in
Fig. 3B, a sizeable fraction of eIF4E and 4E-BP1 was present into
the nucleus. Moreover, hypoxia caused a shift of eIF4E from the cy-
tosol to the nucleus at both times studied. Colocalization of 4E-BP1
and eIF4E in the nuclear compartment can be observed in some
hypoxic cells (Fig. 3B, arrows).
3.5. Study of the mechanism involved in 4E-BP1 regulation
Hypoxia activates several different pathways producing inhibi-
tion of the translation initiation (Fig. 4A). Thus, hypoxia induces a
reduction in the ATP:ADP ratio within the cell, resulting in the acti-
vation of AMP-activated protein kinase (AMPK) that inhibits mTOR,
which blocks the activity of 4E-BP1. Moreover, hypoxia induces the
hypoxia inducible factor 1 (HIF-1) that activates REDD1 (regulated
in development and DNA damage 1), which also inhibits mTOR
and, therefore, blocks translation in the same manner. Finally, it
has been established that the main signaling pathway that regulates
4E-BP1 phosphorylation is the Akt/mTOR pathway (reviewed in
[20]).
To study if all of these pathways are involved in the 4E-BP1 de-
phosphorylation induced by hypoxia in our model, ﬁrst we tested
the phosphorylation status of Akt/PKB using an antibody that rec-
ognizes Akt when is speciﬁcally phosphorylated at Ser473. Our re-
sults showed that Akt was phosphorylated after hypoxia (Fig. 4B,
Supplemental Fig. S4). Next, the AMPK activation was tested by
two different ways. First, directly by measuring the phosphorylation
of AMPK in the Thr172 and, second, taking into account that eEF2
kinase (eEF2K) is phosphorylated and activated by AMPK, we
have measured the levels of phosphorylated eEF2 in the Thr56,
the residue target of eEF2K. As shown in Fig. 4B, no changes in
the phosphorylation status of AMPK and eEF2 were detected after
4 and 24 h of hypoxia (Supplemental Fig. S4). Finally, we have de-
termined the levels and activity of HIF1α. As shown in Fig. 4C
(top), the levels of HIF1α increased signiﬁcantly at both times stud-
ied. In addition, we performed immunohistochemical studies also
detecting an increased expression of HIF1α as well as a more
prominent presence of this protein into the nucleus of hypoxic rel-
ative to control cells (Fig. 4C, bottom). The quantiﬁcation of the
levels of HIF1α mRNA showed a signiﬁcant decrease after 24 h of
hypoxia (Fig. 4D) suggesting a posttranscriptional regulation of
the protein as previously described [17]. To corroborate the HIF1α
activation, we have also assessed REDD1 mRNA levels, a protein di-
rectly regulated by HIF1α, that inhibit mTOR through the activation
of tuberous sclerosis complex 1 (TSC1). As shown in Fig. 4D the
levels of REDD1 mRNA increased as soon as 4 h of hypoxia (1.5-
A Cytosol Nucleus
eIF4E
4E-BP1
%O2 21                   0.1            21               0.1  
B
C4
eIF4E4E-BP1 4E-BP1/eIF4E
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C24
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Fig. 3. Subcellular localization of 4E-BP1 and eIF4E in control and hypoxic PC12 cells. A) PC12 cells were subjected to hypoxia for 24 h and cytoplasmic and nuclear fractions
obtained as described in the Materials and methods section. Equivalent volumes of the different fractions were subjected to SDS-PAGE and immunoblotted with anti-eIF4E and
anti-4E-BP1 antibodies. The blot shown is one representative of three independent experiments. B) NGF-differentiated PC12 cells were subjected to 0.1% O2 during 4 h and 24 h
and then processed for immunostaining and analyzed by confocal microscopy as indicated under Materials and methods. Labeled proteins are indicated on top of the panels.
The distribution of 4E-BP1 and eIF4E was monitored with anti-4E-BP1 (53H11) and anti-eIF4E, respectively. The right panel represents a computer-generated overlay of both im-
ages. For the analysis, green and red colors were assigned arbitrarily to the left and right images, respectively. Yellow color indicates overlap. Pictures were taken with a confocal
microscope (Nikon) at 60×. Arrows indicate nucleus showing colocalization of eIF4E and 4E-BP1. The images shown are from representative ﬁelds of each sample. The experiment
was performed at least three times, with similar results.
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mined by western blot analysis, REDD1 expression was signiﬁcantly
increased (Fig. 4E).
To further assess the role of REDD1 in the hypoxia-induced 4E-BP1
dephosphorylation, REDD1 expression was silenced by RNA interfer-
ence. As shown in Fig. 5A, REDD1 siRNA downregulated REDD1 ex-
pression to 50% in control cells. After 4 h of hypoxia, REDD1 siRNA
almost completely abrogated hypoxia-mediated REDD1 induction,
being partially downregulated at 24 h of hypoxia (up 60%). Although
after a short time of hypoxia, downregulation of REDD1 does not lookaffect the 4E-BP1 dephosphorylation, this is prevented signiﬁcantly at
24 h of hypoxia (Fig. 5B).
4. Discussion
It is generally established that hypoxia (poor oxygenation) induces
overall protein synthesis inhibition that is primarily regulated at the
level of initiation step. This regulation generally takes place at two
stages: the phosphorylation of the subunitα of eIF2 and the inhibition
of the eIF4F complex availability by dephosphorylation of the
AC D
E
B
Fig. 4. Study of the mechanism involved in 4E-BP1 regulation. A) Model of the pathways regulating 4E-BP1 phosphorylation via mTOR. Hypoxia induces a reduction in the ATP:
ADP ratio within the cell, resulting in the activation of AMPK. AMPK inhibits mTOR, which block the activity of 4E-BP1. Hypoxia induces HIF-1 that activates REDD1, which also
inhibits mTOR. The main signaling pathway that regulates 4E-BP1 phosphorylation is the Akt/mTOR pathway. B) Analysis of the phosphorylation of Akt/PKB, AMPK and eEF2
by Western blot. Phosphorylation of each protein was checked using sequentially phosphospeciﬁc antibodies (AktP (Ser473), AMPKP (Thr172) or eEF2P (Thr56)) and anti-Akt,
AMPK and eEF2 antibodies respectively, in control and hypoxic cells after 4 h and 24 h. Representative blots are shown and the quantiﬁcation of the western blots is shown in
the Supplemental material. C) Analysis by Western blot of the levels of HIF1α in cell lysates from control or hypoxic cells after 4 h and 24 h, obtained as described in the
Materials and methods section and immunoblotted with anti-HIFα antibody (R&D). Fast green was used as a loading control (top). Immunohistochemical studies of control
and hypoxic cells after 24 h were performed (bottom). Nuclei were stained with DNA-binding dye Hoeschst 33342 (blue; left panels) and the distribution of HIF1α was mon-
itored with anti-HIFα antibody from Santa Cruz Biotechnology (green; right panels) (objective 40×). D) Quantiﬁcation of the levels of HIF1α and REDD1 mRNAs by qRT-PCR in
control and hypoxic cells after 4 h and 24 h. Data are normalized relative to P0 mRNA levels and the value for the control was considered as 1. Each experiment was done in
triplicate twice and data corresponding to the mean±SEM of RNA from four different extractions. Statistical signiﬁcance: *pb0.05; **pb0.01. E) Analysis by Western blot of
the levels of REDD1 in cell lysates from control or hypoxic cells after 4 h and 24 h, obtained as described in the Materials and methods section and immunoblotted with anti-
REDD1 antibody. The blots shown are one representative of six independent experiments. β-Actin was used as loading control.
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the implication of these mechanisms of translational regulation in
the hypoxia has been motivated by the clinical importance of tumor
hypoxia and, consequently, almost all works have been donewith pro-
liferating cells. Up to our knowledge, this is the ﬁrst study that deeps
in the translational regulation during hypoxia in differentiated no pro-
liferating cells. Moreover, the rat phaeochromocytoma cell line PC12,
after exposure to nerve growth factor (NGF), stops to proliferate and
develops features of sympathetic neurons which make differentiatedPC12 cells being an useful model for the study of neurobiology prob-
lems, such as ischemia ([21–23]) or hypoxia (this paper).
Previous studies have reported that 0.1% O2 may be considered
as severe hypoxia, although other reports judge this percentage as
the limit between moderated and severe hypoxia [7], and others
as moderate hypoxia [24]. In this paper, we subject the cells to
0.1% O2 for a short (4 h) and a prolonged (24 h) period of time to
evaluate the effect of hypoxia on the control points of the transla-
tion initiation (ternary complex and eIF4F complex availability).
AB
Fig. 5. Effect of REDD1 siRNA on 4E-BP1 phosphorylation status. A) Differentiated PC12
cells were transfected with a nonspeciﬁc (NS) or REDD1 (REDD1) siRNA, 72 h post-
transfection were subjected to 0.1% O2 during 4 h and 24 h and cell lysates obtained
as described in the Materials and methods section. Expression level of REDD1 and
phosphorylation status of 4E-BP1 were analyzed by Western blot using anti-REDD1
and 4E-BP1 antibodies, respectively. β-Actin was used as loading control. The blots
shown are one representative of three independent experiments. B) Quantiﬁcation of
the phosphorylation status of 4E-BP1. Bands corresponding to the isoform α of 4E-
BP1 were analyzed as described under “Materials and methods” and the results are
expressed as the percentage of α isoform with respect to total 4E-BP1. Bars represent
the mean±SEM of 3 independent experiments. Statistical signiﬁcance: versus control
cells, *pb0.05; **pb0.01; ***pb0.001; versus hypoxic cells, apb0.001.
HYPOXIA
HIF-1α
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Fig. 6.Model of the pathway regulating protein synthesis in response to hypoxia. Hyp-
oxia induces HIF-1 that activates REDD1, which inhibits mTOR through TSC1/2 com-
plex. Finally, the inhibition of mTOR activity prevents 4E-BP1 phosphorylation. In
parallel, hypoxia produces redistribution of eIF4E from cytosol to the nucleus via its in-
teraction to 4E-T.
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fect the phosphorylation status of eIF2α which is in agreement
with other studies showing that eIF2α phosphorylation did not in-
crease in cells subjected to moderate and severe hypoxia during 5 h
[25]. In spite of that we cannot discard an increased eIF2αP at
shorter times (30 min or 1 h), as described previously in severe
hypoxia models [5,6], the phosphorylation of this factor does not
look responsible of the translation inhibition observed in these con-
ditions. At this time, the close correlation between 4E-BP1 dephos-
phorylation and decrease of eIF4F complex formation and protein
synthesis rate suggests that this pathway could be the responsible
of the translation inhibition. This correlation was maintained
under prolonged hypoxia indicating the importance of the 4E-BP1
in regulating overall mRNA translation during this phenomenon;
however, the possible contribution of the increase of eIF2αP ob-
served at this time should not be discarded. Interestingly, our re-
sults show an increase in the level of both 4E-BP1 and its mRNA
after hypoxia. Several reports have showed changes in the levels
of 4E-BP1 in different situations, such as seasonal and state-
dependent modiﬁcations during the hibernation [26], or increased
expression in many cancers including breast and ovarian [27] that
is associated with worse prognosis and advanced stage of disease
[28,29]. On the other hand, it has been demonstrated that tumorcells having low 4E-BP1 expression showed decreased susceptibility
to hypoxia [30]. However, in these studies the mechanism control-
ling 4E-BP1 expression has not been investigated yet. Our ﬁndings
suggest that a transcriptional control could be involved in the in-
crease of 4E-BP1 found in our model, at least after prolonged hyp-
oxia exposition. Nevertheless, whether or not 4E-BP1 mRNA could
be target of HIF1α remains to be elucidated.
A potential cause of eIF4F disruption is the translocation of eIF4E
into the nucleus, mediated by the shuttling protein eIF4E transporter
(4E-T) [31]. Our ﬁndings indicate that hypoxia causes a redistribution
of eIF4E from the cytosol to the nucleus in differentiated PC12 cells.
This translocation occurs as early as 4 h of treatment. Then, nuclear
4E-BP1 might prevent the shuttling of eIF4E to the cytosol decreasing
eIF4E availability to participate in eIF4F complex formation. These re-
sults are consistent with Koritzinsky et al. [5] who described that hyp-
oxia causes a redistribution of eIF4E from cytoplasm to the nucleus
and, more recently, Rong et al. [19] indicated that the 4E-BP1 is local-
ized partly into the nucleus and regulates nuclear eIF4E levels by
retaining it under stress conditions.
The association of 4E-BPs with eIF4E is regulated by phosphoryla-
tion, mediated mainly by mTOR. The mechanism of inhibition of
mTOR seems to be rather complicated. Up to date, the ﬁndings indi-
cate that hypoxia can induce a decrease in cellular energy levels, lead-
ing to the activation of AMPK that would regulate mTORC1 by
phosphorylation of the TSC2 [32] and activation of TSC1/2 complex
or/and phosphorylation of Raptor. An alternative or parallel HIF-
dependent pathway of mTOR regulation implicates the protein
REDD1 that is induced by hypoxia and activates the TSC1/2 complex.
In our model, several ﬁndings strongly support a role for this second
mechanism: i) AMPK activation does not occur in any of the times
of hypoxia studied, ii) hypoxia induces an increase in both functional
HIF1α and HIF-mediated REDD1 expression and iii) downregulation
of REDD1 produces the reversion in the phosphorylation status of
4E-BP1.
In conclusion, we have found that hypoxia cause protein synthesis
inhibition, mainly regulated by eIF4F disruption. Our results strongly
438 M. Hernández-Jiménez et al. / Biochimica et Biophysica Acta 1823 (2012) 430–438support that two mechanisms are involved in the inhibition of eIF4F
complex formation. One of them would implicate 4E-BP1 dephos-
phorylation produced by the inhibition of mTOR activity via the acti-
vation of REDD1 protein in a HIF1-dependent manner; and the
second through the translocation of eIF4E to the nucleus, probably
mediated via its interaction with 4E-T (Fig. 6).
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